Clostridioides difficile infection (CDI) remains a significant clinical challenge both in the
management of severe and severe-complicated disease and the prevention of recurrence …

Background Our objective was to determine if oral vancomycin, fidaxomicin, and oral
metronidazole use in the United States changed after publication of revised clinical practice …

Abstract Background Nosocomial Clostridioides difficile infection (CDI) complicates up to 1%
of all hospital admissions and is associated with considerable health burden. Aims To …

Background Current guidelines have unsatisfied performance in predicting severe outcomes
after Clostridium difficile infection (CDI). Our objectives were to develop a risk prediction …

Background Despite the growing clinical and economic burden of Clostridioides difficile
infection (CDI), data on CDI in the intensive care unit (ICU) in the Asia-Pacific region are …

The aim of this study was to compare clinical cure rate, recurrence rate and time to
resolution of diarrhea in patients with severe and severe-complicated Clostridium difficile …

Clostridioides difficile (C. difficile) is a predominant nosocomial infection, and guidelines for
improving diagnosis and treatment were published in 2017. We conducted a single-center …

This study was conducted to investigate the adherence to clinical practice guidelines (CPGs)
for Clostridium difficile infection (CDI). A retrospective multicenter observational study was …

AIMS OF THE STUDY Clostridioides difficile infection (CDI) is associated with high
morbidity, recurrence rates and mortality. We assessed the local epidemiology, treatment …

Management of Clostridium difficile infection (CDI) involves discontinuation of the offending
antibiotic agent as soon as possible. However, the ongoing infection does not allow …